References
- World Health Organization. Tropical Diseases Research progress, 1997–98. Fourteenth Programme Report‐Leishmaniasis. 1998; 1–22
- Murray H. W., Berman J. D., Wright D. C. Immunochemotherapy for Leishmania donovani infection: γ‐interferon plus pentavalent antimony. J. Infect. Dis. 1988; 157: 973–978, [PUBMED], [INFOTRIEVE]
- Badaro R., Nascimento C., Carvalho J. S., Badaro F., Russo D., Ho J. L., Reed S. G., Johnson W. D., Jr., Jones T. C. Recombinant human granulocyte macrophage colony stimulating factor reserves neutropenia and reduces secondary infections in visceral leishmaniasis. J. Infect. Dis. 1994; 170: 413–418, [PUBMED], [INFOTRIEVE]
- Smith A. C., Yardley V., Rhodes J., Croft S. L. Activity of the novel immunomodulatory compound Tucaresol against experimental visceral leishmaniasis. Antimicrob. Agent Chemother. 2000; 44: 1494–1498, [CROSSREF]
- Parker F., Migliore‐Samour D., Floc'H F., Zerial A., Werner G. H., Jolles J., Casaretto M., Zahn H., Jolles P. Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. Eur. J. Biochem. 1984; 145: 677–682, [PUBMED], [INFOTRIEVE]
- Sahai R., Puri A., Saxena R. P., Saran R., Haq W., Kundu B., Mathur K. B. Synthesis and immunostimulant activity of novel analogs of human casein fragment (54–59). Immunopharmacol. Immunotoxicol. 1996; 18(4)511–528, [PUBMED], [INFOTRIEVE]
- Sharma P., Anurahda, Sharma R., Haq W., Kundu B., Katiyar J. C., Mathur K. B. Stimulation of non‐specific resistance by human casein fragment (54–59) and its synthetic analogues against Leishmania donovani infection. Prot. Pep. Lett. 1996; 3: 261–266
- Koning W., Geiger R. Eine neue Methode Zur synthase von peptiden: Aktivierung der carboxygruppe mit Diyclohexyl carbodiimid unter Zusatz von 1‐Hydroxy‐benzotriazoler. Chem. Ber. 1970; 103: 788
- Moroder L., Hallett A., Wunsch E., Keller O., Wessin G. Diterbutyl‐dicarbonate, a useful reagent for the introduction of the tertbutyl‐oxycarbonyl protector group. Hoppe‐Seyler's Z‐Physiol. Chem. 1976; 357: 1651
- Sharan R., Kundu B., Mathur K. B. Synthesis of immunostimulating hexapeptide corresponding to sequence 54–59 of human β‐casein. Indian J. Chem. 1991; 30B: 728
- Laufer D. A., Blout E. R. A new stepwise synthesis of an octopeptide corresponding to a sequence around the ‘Reactive’ serine of chymotrypsin. J. Am. Chem. Soc. 1967; 89: 1246, [PUBMED], [INFOTRIEVE]
- Schroder E. Syntheses des all‐D‐Val5‐Angiotensin II‐ASP1‐β amides leibig's Ann. 1966; 692: 241
- Puri A., Rizvi S. Y., Haq W., Saxena R. P., Guru P. Y., Kundu B., Shukla R., Mathur K. B., Saxena K. C. Immunostimulant activity of novel lipopeptide and its protective action against Leishmania donovani. Immunopharmacol. Immunotoxicol. 1993; 15: 539–556, [PUBMED], [INFOTRIEVE]
- Jerne N. K., Nordin A. A. Plaque formation in agar by single antibody producing cells. Science 1963; 140: 405–407
- Saiki I., Tanio Y., Yamawaki M., Uemiya M., Kobayashi S., Fukuda T., Yukimasa H., Yamamura Y., Azuma I. Adjuvant activity of quinonyl‐N‐acetyl muramyl dipeptides in mice and guinea pigs. Infect. Immun. 1981; 31: 114–121, [PUBMED], [INFOTRIEVE]
- Saxena K. C., Puri A., Saxena R., Saxena R. P. Macrophage migration as an index of immune status. Immun. Invest. 1991; 20: 431–440
- Leijh P. C.J., Van Den Barrclaar M. T., Van Furth R. Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect. Immun. 1977; 17: 313–318, [PUBMED], [INFOTRIEVE]
- Takada H., Tsujimoto M., Kato K., Katani S., Kusumoto S., Inage M., Shiba T., Yano I., Kawata S., Yokogawa K. Macrophage activation by bacterial cell walls and related synthetic compounds. Infect. Immun. 1979; 25: 48–53, [PUBMED], [INFOTRIEVE]
- Beveridge E. Chemotherapy of leishmaniasis. Experimental Chemotherapy, R. J. Schnitzer, F. Hawking. Academic Press, New York 1963; Vol. 1: 257–280
- Bhatnagar S., Guru P. Y., Katiyar J. C., Srivastava R., Mukherjee A., Akhtar M. S., Seth M., Bhaduri A. P. Exploration of antileishmanial activity in heterocycles: results of their in vivo and in vitro bioevaluations. Indian J. M. R. 1989; 89: 439
- Pal R., Anuradha, Rizvi S. Y., Kundu B., Mathur K. B., Katiyar J. C. Leishmania donovani in hamsters: stimulation of non‐specific resistance by some novel glycopeptides and impact on therapeutic efficacy. Experientia 1999; 47: 486–490
- Zehra K., Pal R., Anuradha, Rizvi S. Y., Haq W., Kundu B., Katiyar J. C., Mathur K. B. Leishmnaia donovani in hamsters: stimulation of non‐specific resistance by novel lipopeptides and their effect in antileishmanial therapy. Experientia 1995; 51: 725–730, [PUBMED], [INFOTRIEVE]